These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8886876)

  • 1. Symposium: ovarian tumors of borderline malignancy.
    Silva EG; Kurman RJ; Russell P; Scully RE
    Int J Gynecol Pathol; 1996 Oct; 15(4):281-302. PubMed ID: 8886876
    [No Abstract]   [Full Text] [Related]  

  • 2. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    McKenney JK; Balzer BL; Longacre TA
    Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic vascular invasion in ovarian serous tumors of low malignant potential with stromal microinvasion: a case control study.
    Sangoi AR; McKenney JK; Dadras SS; Longacre TA
    Am J Surg Pathol; 2008 Feb; 32(2):261-8. PubMed ID: 18223329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An unusual ovarian tumor].
    Goutallier-Ben Fadhel C; Nfoussi H; Znaidi N; Boufaroua A; Bouraoui S; Mzabi-Regaya S
    Ann Pathol; 2009 Jun; 29(3):252-4. PubMed ID: 19619837
    [No Abstract]   [Full Text] [Related]  

  • 6. Alendronate inhibits intraperitoneal dissemination in in vivo ovarian cancer model.
    Hashimoto K; Morishige K; Sawada K; Tahara M; Kawagishi R; Ikebuchi Y; Sakata M; Tasaka K; Murata Y
    Cancer Res; 2005 Jan; 65(2):540-5. PubMed ID: 15695397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microcystic stromal tumor of the ovary: report of 16 cases of a hitherto uncharacterized distinctive ovarian neoplasm.
    Irving JA; Young RH
    Am J Surg Pathol; 2009 Mar; 33(3):367-75. PubMed ID: 18971779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants.
    Kane A; Uzan C; Rey A; Gouy S; Camatte S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P
    Oncologist; 2009 Jun; 14(6):591-600. PubMed ID: 19487334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. u-PA expression in benign, borderline and malignant ovarian tumors.
    Kiziridou AD; Toliou T; Stefanou D; Agnantis N
    Anticancer Res; 2002; 22(2A):985-90. PubMed ID: 12014682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
    Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC
    Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucinous tumors of the ovary: a review.
    Hart WR
    Int J Gynecol Pathol; 2005 Jan; 24(1):4-25. PubMed ID: 15626914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms.
    Tibiletti MG; Bernasconi B; Furlan D; Bressan P; Cerutti R; Facco C; Franchi M; Riva C; Cinquetti R; Capella C; Taramelli R
    Clin Cancer Res; 2001 Nov; 7(11):3404-9. PubMed ID: 11705855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.
    Huang LW; Garrett AP; Bell DA; Welch WR; Berkowitz RS; Mok SC
    Gynecol Oncol; 2000 Jun; 77(3):369-76. PubMed ID: 10831344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary ovarian carcinoid tumor with luteinized stromal cells.
    Engohan-Aloghe C; Buxant F; Noël JC
    Arch Gynecol Obstet; 2009 Jul; 280(1):119-21. PubMed ID: 19039598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer.
    Gotlieb WH; Chetrit A; Menczer J; Hirsh-Yechezkel G; Lubin F; Friedman E; Modan B; Ben-Baruch G;
    Gynecol Oncol; 2005 Jun; 97(3):780-3. PubMed ID: 15893369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case 2. Spontaneous regression of peritoneal implants in borderline ovarian tumor after salpingo-oophorectomy.
    Morice P; Thoury A; Sabourin JC; Camatte S; Atallah D; Armand JP; Madelenat P; Duvillard P; Castaigne D
    J Clin Oncol; 2003 Sep; 21(18):3536-8. PubMed ID: 12972532
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.
    Chang SJ; Ryu HS; Chang KH; Yoo SC; Yoon JH
    Acta Obstet Gynecol Scand; 2008; 87(4):476-81. PubMed ID: 18382877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary.
    Ronnett BM; Shmookler BM; Sugarbaker PH; Kurman RJ
    Anat Pathol; 1997; 2():197-226. PubMed ID: 9575376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel screening technique for dissemination potential of ovarian cancer cells to peritoneum.
    Fujimoto J; Hori M; Ichigo S; Morishita S; Tamaya T
    Invasion Metastasis; 1996; 16(6):302-7. PubMed ID: 9371229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
    Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
    Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.